Sildenafil or Bosentan in Patients Considered Inelegible for Heart Transplantation Because of Severe Pulmonary Hypertension

被引：1
|
作者：
Farrero, M. [1 ]
Perez-Villa, F. [1 ]
Arias, A. [1 ]
Stonis, A. [1 ]
Castel, A. [1 ]
Roig, E. [1 ]
机构：
[1] Hosp Clin Barcelona, Thorax Inst, Barcelona, Spain
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2009年 / 28卷 / 02期
关键词：
D O I：
10.1016/j.healun.2008.11.581
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
574
引用
收藏
页码：S265 / S265
页数：1
相关论文
共 50 条
  • [1] Slidenafil or Bosentan in Patients Considered Inelegible Heart Transplantation Because of Severe Pulmonary Hypertension
    Farrero, Maria
    Villa, Felix Perez
    Arias, Adrian
    Castel, Maria Angeles
    Sionis, Alessandro
    Roig, Eulalia
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A180 - A180
  • [2] Effects of Bosentan in Patients Considered Ineligible for Heart Transplantation Because of Severe Pulmonary Hypertension
    Tatier, I.
    Farrero, M.
    Cardona, M.
    Pensa, D.
    Castel, A.
    Perez-Villa, F.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S53 - S53
  • [3] Initial experience with bosentan therapy in patients considered ineligible for heart transplantation because of severe pulmonary hypertension
    Perez-Villa, F
    Cuppoletti, A
    Rossel, V
    Vallejos, I
    Roig, E
    CLINICAL TRANSPLANTATION, 2006, 20 (02) : 239 - 244
  • [4] Therapy with sildenafil or bosentan decreases pulmonary vascular resistance in patients ineligible for heart transplantation because of severe pulmonary hypertension
    Perez-Villa, Felix
    Farrero, Marta
    Sionis, Alessandro
    Castel, Angeles
    Roig, Eulalia
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (07): : 817 - 818
  • [5] Combination therapy with Sildenafil and Bosentan reverts severe pulmonary hypertension and allows heart transplantation:: Case report
    Mogollon, M. V.
    Lage, E.
    Cabezon, S.
    Hinojosa, R.
    Ballesteros, S.
    Aranda, A.
    Sobrino, J. M.
    Ordonez, A.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (08) : 2522 - 2523
  • [6] Treatment of Patients with Severe Pulmonary Arterial Hypertension Secondary to Congenital Heart Disease with Bosentan and Sildenafil
    Zhu, Xianyang
    Zhang, Duanzhen
    Meng, Jing
    Sheng, Xiaotang
    CIRCULATION, 2010, 122 (02) : E238 - E238
  • [7] Impact of sildenafil treatment on pulmonary hemodynamics and outcomes in patients with severe pulmonary hypertension receiving heart transplantation
    Senechal, M.
    Pons, J.
    Bernier, M.
    Cantin, B.
    Bourgault, C.
    Bergeron, S.
    Proulx, G.
    Nalli, C.
    Chateauvert, N.
    Leblanc, M. H.
    EUROPEAN HEART JOURNAL, 2012, 33 : 207 - 207
  • [8] THERAPY WITH SILDENAFIL ALLOWS SUCCESSFUL HEART TRANSPLANTATION IN PATIENTS WITH ADVANCED HEART FAILURE AND SEVERE PULMONARY HYPERTENSION
    Pons, J.
    Leblanc, M.
    Cantin, B.
    Bourgault, C.
    Nalli, C.
    Senechal, M.
    CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (05) : S226 - S226
  • [9] Bosentan in heart transplantation candidates with severe pulmonary hypertension: efficacy, safety and outcome after transplantation
    Perez-Villa, Felix
    Farrero, Marta
    Cardona, Montse
    Castel, Maria Angeles
    Tatjer, Irene
    Penela, Diego
    Vallejos, Isabel
    CLINICAL TRANSPLANTATION, 2013, 27 (01) : 25 - 31
  • [10] Heart transplantation in patients with severe pulmonary hypertension
    Al-Hiti, H.
    Malek, I.
    Kettner, J.
    ADVANCES IN HEART DISEASE, 2006, : 615 - +
12345